| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/09/2001 | WO2001007649A3 Method for detecting microorganisms |
| 08/09/2001 | WO2001007647A3 Method for relative quantization of methylation of cytosin-type bases in dna samples |
| 08/09/2001 | WO2001007641A3 Method for expressing a library of nucleic acid sequence variants and selecting desired traits |
| 08/09/2001 | WO2001007574A3 Modified cytochrome p450 monooxygenases |
| 08/09/2001 | WO2001007451A3 Isolation of biomolecules |
| 08/09/2001 | WO2001007066A3 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 08/09/2001 | WO2001006228A3 High density electrophoresis device and method |
| 08/09/2001 | WO2001006004A3 A method for amplifying low abundance nucleic acid sequences and means for performing said method |
| 08/09/2001 | WO2001004351A3 Genetic test for detecting a predisposition to a disease associated with abnormal vegf gene expression |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2001004316A3 Antigenic meningococcal peptides |
| 08/09/2001 | WO2001002827A9 Biosensor |
| 08/09/2001 | WO2000078991A3 Process for removing systematic error and outlier data and for estimating random error in chemical and biological assays |
| 08/09/2001 | WO2000078364A3 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood |
| 08/09/2001 | WO2000073499A3 Nucleic acid probes and methods for detecting clinically important fungal pathogens |
| 08/09/2001 | WO2000070097A3 Profile searching in nucleic acid sequences using the fast fourier transformation |
| 08/09/2001 | WO2000070085A3 Method for detecting the effect of different chemotherapeutic agents and/or radiation therapy in malignant diseases |
| 08/09/2001 | WO2000070046A9 Secreted polypeptides and corresponding polynucleotides |
| 08/09/2001 | WO2000068421A3 Method for detecting microorganisms in a sample |
| 08/09/2001 | WO2000065098A9 Nucleotide extension on a microarray of gel-immobilized primers |
| 08/09/2001 | WO2000065088A3 Primers for identifying typing or classifying nucleic acids |
| 08/09/2001 | WO2000063351A3 Carbohydrate-modifying enzymes |
| 08/09/2001 | WO2000058510A3 Schizophrenia associated genes, proteins and biallelic markers |
| 08/09/2001 | WO2000056929A3 Coupled polymerase chain reaction-restriction endonuclease digestion-ligase detection reaction process |
| 08/09/2001 | WO2000056924A3 Genomic sequence of the purh gene and purh-related biallelic markers |
| 08/09/2001 | WO2000037643A3 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 08/09/2001 | US20010013134 Transgenic mammal; polynucleotide containing pancreas promoter |
| 08/09/2001 | US20010012983 Methods for determining therapeutic index from gene expression profiles |
| 08/09/2001 | US20010012836 Determining the presence or absence of a mutation in the nucleotide sequence or absence of a mutation in nucleotide sequence encoding the specific polypeptides in the genome of the subject and analyzing for presence of polypeptide |
| 08/09/2001 | US20010012627 Neurotransmitter transporter SC6 |
| 08/09/2001 | US20010012626 Polynucleotides encoding Presenilin 1 (PS1); diagnosing a patient having an increased likelihood of contracting Alzheimer's disease |
| 08/09/2001 | US20010012623 Detection of H. pylori in the stomach |
| 08/09/2001 | US20010012622 Method for isolating inhibitors of protease activity |
| 08/09/2001 | US20010012621 Determining the expression of lysyl oxidase, the expression of lysyl oxidase indicating that the compound is capable of suppressing ras functions |
| 08/09/2001 | US20010012619 Novel cancer drug screen based on cell cycle uncoupling |
| 08/09/2001 | US20010012617 For preparing cDNA from a mRNA using a reverse transcriptase where the reverse transcription is performed at a temperature at which mRNA do not take a secondary structure; improved heat stability of RNA by including metal ion chelator |
| 08/09/2001 | US20010012616 Probe including a crosslinking agent hybridized with target sequence, then conditions are change to allow crosslinking and sample is separated by gel electrophoresis where mismatches have different migratory rate; kits |
| 08/09/2001 | US20010012614 Nucleotide sequence from mRNA untranslated regions encoding RNA binding proteins (RBPs) binding proteins; use in drug screening; use in modifying post-transcriptional protein expression |
| 08/09/2001 | US20010012613 Mutating at least one amino acid residue of a thermostable polymerase and screening said population for active polymerase mutants by genetic selection; diagnosing a genetic disease |
| 08/09/2001 | US20010012537 Placing a solid such as castor wax which has entrapped biological macromolecules therein, degrading the matrix such as by melting to remove the matrix, and retaining the biological molecules uniformly adhered to the surface |
| 08/09/2001 | US20010012515 Isolated polypeptide |
| 08/09/2001 | DE10030945A1 Verwendung einer Genveränderung im Gen für die beta3-Untereinheit des humanen G-Proteins Use of a gene change in the gene for the beta3-subunit of the human G-protein |
| 08/09/2001 | DE10004147A1 Oligonucleotides for the amplification and qualitative and quantitative detection of bacterial 16S rRNA useful to determine bacterial contamination of foodstuffs, waters, and in clinical microbiology |
| 08/09/2001 | DE10003763A1 Verfahren und Vorrichtung zur Detektion von DNA-Sequenzen in gentechnisch veränderten Organismen Method and device for the detection of DNA sequences in genetically modified organisms |
| 08/09/2001 | DE10003521A1 Vorrichtung zum Herstellen eines dreidimensionalen Matrixkörpers, Multi-Well-Platte, Lösung zum Kultivieren von Säugerkardiomyocyten, Verfahren zum Kultivieren einer Zellkultur, Vorrichtung für die Messung isometrischer Kraftparameter von Zellkulturen sowie Verfahren zum meßbaren Verfolgen von Kontraktionen eines in eine Trägersubstanz eingelagerten Zellgewebes Apparatus for producing a three-dimensional matrix body, multi-well plate solution for culturing mammalian cardiomyocytes, methods for culturing a cell culture device for measuring isometric force parameters of cell cultures and methods for measurable following of contractions of an embedded into a carrier subcutaneous tissue |
| 08/09/2001 | DE10002819A1 Nachweissystem zur Prüfung der Originalität eines Objekts und Testvorrichtung zur Durchführung der Prüfung Detection system for checking the authenticity of an object and testing device for carrying out the test |
| 08/09/2001 | CA2401962A1 Nucleic acid detection methods using universal priming |
| 08/09/2001 | CA2400013A1 Methods of protein destabilization and uses thereof |
| 08/09/2001 | CA2400006A1 Signaling aptamers that transduce molecular recognition to a differential signal |
| 08/09/2001 | CA2399982A1 G-protein coupled receptors |
| 08/09/2001 | CA2399686A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | CA2399683A1 Mammalian sphingosine-1-phosphate phosphatase |
| 08/09/2001 | CA2399672A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides |
| 08/09/2001 | CA2399649A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2399644A1 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | CA2399333A1 Method for identifying and/or characterizing a (poly)peptide |
| 08/09/2001 | CA2399149A1 Plant adpglucose pyrophosphatase, process for the production, use in themanufacture of assay devices and in producing transgenic plants |
| 08/09/2001 | CA2399141A1 Use of a mutation in the gene for the .beta.3-subunit of human g-protein |
| 08/09/2001 | CA2399032A1 Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection |
| 08/09/2001 | CA2398877A1 Nucleic acids, proteins, and antibodies |
| 08/09/2001 | CA2398810A1 Cast analyte diffusion-limiting membranes using photopolymerizable hydrophylic monomers |
| 08/09/2001 | CA2398789A1 Process for detecting modulation of nad(p)h oxidoreductase |
| 08/09/2001 | CA2398757A1 Assay |
| 08/09/2001 | CA2398250A1 Interaction of nmda receptor with protein tyrosine phosphatase |
| 08/09/2001 | CA2398215A1 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2398168A1 Polynucleotide arrays and their use in sequencing |
| 08/09/2001 | CA2396774A1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/09/2001 | CA2388283A1 Reagent test strip for analyte determination |
| 08/09/2001 | CA2369742A1 Methods of generating protein expression arrays and the use thereof in rapid screening |
| 08/08/2001 | EP1122542A1 Method for the rapid detection of whole microorganisms on retaining membranes by use of chaotropic agents |
| 08/08/2001 | EP1122318A2 Diagnostic method for the detection of polymorphisms related to the human urokinase plasminogen activator receptor |
| 08/08/2001 | EP1121938A2 Prevention of sudden infant death |
| 08/08/2001 | EP1121600A2 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 08/08/2001 | EP1121597A1 Screen for risk for gastric adenocarcinoma |
| 08/08/2001 | EP1121596A1 Microarray system and process for performing biochemical reactions |
| 08/08/2001 | EP1121593A2 Method for extracting quantitative information relating to an influence on a cellular response |
| 08/08/2001 | EP1121588A1 Multi-array microsystem for chemical or biological analysis |
| 08/08/2001 | EP1121582A2 Novel optical architectures for microvolume laser-scanning cytometers |
| 08/08/2001 | EP1121472A2 Systems and methods for sequencing by hybridization |
| 08/08/2001 | EP1121471A1 Nucleic acid arrays |
| 08/08/2001 | EP1121470A1 Methods for manipulating complex nucleic acid populations using peptide-labeled oligonucleotides |
| 08/08/2001 | EP1121469A2 Method and kit for directly detecting nucleotide sequences, amino acid sequences or antigens |
| 08/08/2001 | EP1121468A1 Metabolic selection methods |
| 08/08/2001 | EP1121467A2 Automatable quick test for direct detection of apc resistance mutation with specific primers and assay |
| 08/08/2001 | EP1121466A1 Carcinogen assay |
| 08/08/2001 | EP1121465A1 Template chain reaction |
| 08/08/2001 | EP1121464A1 Polymorphism in a tgf-ss gene correlated to osteoporosis |
| 08/08/2001 | EP1121463A1 Improved hybridisation assay in which excess probe is destroyed |
| 08/08/2001 | EP1121462A2 Genes for assessing cardiovascular status and compositions for use thereof |
| 08/08/2001 | EP1121461A1 Fluorescent probes for chromosomal painting |
| 08/08/2001 | EP1121460A1 Methods and means for isolating and purifying nucleic acids on surfaces |
| 08/08/2001 | EP1121459A2 Color compensation for temperature and electronic gains |
| 08/08/2001 | EP1121458A1 Methods for assessing complement activation |
| 08/08/2001 | EP1121457A1 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect |
| 08/08/2001 | EP1121454A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 08/08/2001 | EP1121445A2 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
| 08/08/2001 | EP1121444A2 Protein kinase homologs |
| 08/08/2001 | EP1121438A2 p53 BINDING AREAS |
| 08/08/2001 | EP1121437A2 Metastatic breast and colon cancer regulated genes |
| 08/08/2001 | EP1121433A2 Human ankyrin family protein |